Fox Chase Cancer Center News

PHILADELPHIA (September 27, 2022)—In a recently published study, researchers at Fox Chase Cancer Center and Temple University found that only a few so called “leader cells” are necessary for metastasis of breast cancer—the spread of cancer cells from their point of origin to other parts of the body—to occur. The finding underscores the need for more personalized and targeted approaches to fighting cancer.

PHILADELPHIA (September 16, 2022)— The National Comprehensive Cancer Network^® (NCCN^®) hosted a policy summit to examine practice changes and trends in legislative and regulatory efforts that affect patient access to cancer screening and risk reduction.

PHILADELPHIA (September 15, 2022)—Researchers at Fox Chase Cancer Center have been awarded a three-year $250,000 grant to investigate methods of improving the cardiovascular management of patients with prostate cancer being treated with androgen deprivation therapy (ADT).

PHILADELPHIA (September 15, 2022)—Researchers at The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center have found that a new synthetic lethal agent could be an effective treatment for pancreatic cancers with DNA damage repair (DDR) defects.

PHILADELPHIA (September 15, 2022)—The Supportive Oncology and Palliative Care Program (SOPCP) at Fox Chase Cancer Center has earned Joint Commission Advanced Palliative Care Certification, marking the fourth consecutive time the program has achieved this distinction.

PHILADELPHIA (September 14, 2022)—Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center, was recently awarded the Merton Bernfield Memorial Award from the American Society for Cell Biology (ASCB), making her one of 18 scientists from across the country to be recognized for their achievements in the life sciences.

PHILADELPHIA (September 13, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Anthony M. Villano, MD, as a clinical instructor in the Department of Surgical Oncology.

PHILADELPHIA (September 12, 2022)—Camille Ragin, PhD, MPH will serve as co-chair and participate in a panel discussion at this year’s 15th Annual American Association for Cancer Research (AACR) Conference.